| Roche Enlists Dyno to Bring AI to Next-Generation Liver, CNS Gene Therapies | Frank Vinluan | 10/14/20 | Boston |
| Now Closer to Clinical Trials, Codiak BioSciences Refiles IPO Plans | Frank Vinluan | 09/10/20 | Boston |
| Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More | Frank Vinluan | 08/28/20 | National |
| Vesigen Nabs $28M to Wrap “ARMMS” Around Large Molecule Drug Delivery | Frank Vinluan | 07/22/20 | Boston |
| Roche, Jnana Enter Drug R&D Alliance Targeting Metabolism’s Gatekeepers | Frank Vinluan | 07/21/20 | Boston |
| Akouos Aims for an IPO to Advance Hearing Loss Gene Therapy to Clinic | Frank Vinluan | 06/08/20 | Boston |
| Biotech “Mapmaker” Immunai Launches With $20M to Chart the Immune System | Frank Vinluan | 05/14/20 | New York |
| With Harvard Tech and $5M, PIC Therapeutics Takes Aim at Cancer | Frank Vinluan | 04/15/20 | Boston |
| Axsome Plans to Try Again After Failure in Treatment-Resistant Depression | Frank Vinluan | 03/30/20 | New York |
| Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More | Frank Vinluan | 01/31/20 | National |
| eGenesis Lands $100M to Advance CRISPR-ed Pig Kidney to Human Test | Frank Vinluan | 11/07/19 | Boston |
| Nobel Prize in Medicine Goes to 3 Who Showed How Cells Sense Oxygen Levels | Frank Vinluan | 10/07/19 | National |
| Three Biotechs Raise $320M in IPOs, Two Others Pass on Wall Street | Frank Vinluan | 10/03/19 | National |
| Beam Therapeutics Preps IPO and Sheds Light on Its Gene-Editing Drugs | Frank Vinluan | 09/27/19 | Boston |
| Boston Tech Watch: DataRobot, IBM-MIT, Firefly, Aliro, Embr & More | Brian Dowling | 09/20/19 | Boston |
| Gilliland to Step Down as Head of Fred Hutch in 2020 | Jeff Buchanan | 09/17/19 | Seattle |
| Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds | Frank Vinluan | 09/06/19 | Boston |
| Vertex Bets $950M on Semma and a Stem Cell Therapy for Diabetes | Frank Vinluan | 09/03/19 | Boston |
| Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More | Frank Vinluan | 08/02/19 | National |
| Bio Roundup: Leiden’s Exit, Depression Data, a New Pricing Bill & More | Ben Fidler | 07/26/19 | National |
| TScan Lands $48M for Better, Safer T-Cell Receptor Cancer Therapies | Frank Vinluan | 07/24/19 | Boston |
| Quantum Computing 101: Brilliant, Google, Microsoft Training Workers | Bernadette Tansey | 05/31/19 | San Francisco |
| WI Watchlist: Dark Knight Fund, Morgridge “Flamingo” Grant & More | Jeff Bauter Engel | 03/27/19 | Wisconsin |
| Boston Tech Watch: Notarize, Optimus Ride, LogRocket & More | Brian Dowling | 03/22/19 | Boston |
| Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More | Frank Vinluan | 03/15/19 | National |
| Helmet Maker Vicis Courts NFL QBs to Invest in Latest Funding Round | Jeff Buchanan | 02/05/19 | Seattle |
| X·CON 2018: Photos From Three Innovation Days in November | Gregory T. Huang | 11/19/18 | Boston |
| Reuters Report Ranks U-M Among World’s Most Innovative Universities | Sarah Schmid Stevenson | 10/12/18 | Detroit Ann Arbor |
| Human Augmentation, Throwable Robots & More at X·CON, Nov. 4-6 | Gregory T. Huang | 09/24/18 | Boston |
| SQZ Biotech Adds $72M as Cell Therapy Investment Keeps Burning Hot | David Holley | 08/08/18 | Boston |
